Non mainstream pooled investments

RNS Number : 1424W

The MedicX Fund Limited

20 December 2013

 

For immediate release

20 December 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Non mainstream pooled investments

The Board has noted FCA policy Statement PS13/3 and the proposed changes to the FCA rules relating to the restrictions on the retail distribution of unregulated collective investment schemes and close substitutes which will come into effect on 1 January 2014. 

Whilst there is no certainty that the rules will remain as drafted, the Fund has received advice that the Company's shares do meet the definition of excluded securities per PS13/3 because the Company can satisfy sections 1158 and 1159 of the Corporation Tax Act 2010 (which would qualify it for approval as an investment trust if it was resident in the UK). 

The Board confirms that it conducts its affairs, and intends to continue to conduct its affairs, so that the Company's shares will be excluded securities under these new rules and will therefore be excluded from the FCA's restrictions which apply to non-mainstream pooled investment products. 

End

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity                                                          [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                              [phone]

Charles Ryland/Sophie McNulty

MedicX Limited                                                               [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 122 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

END

 

 

MSCNKKDQQBDDBBB